Costs and Barriers of Cancer Screening After Positive Genetic Testing: Are Actionable Mutations Becoming "Unactionable"?
- PMID: 35714670
- DOI: 10.6004/jnccn.2022.7013
Costs and Barriers of Cancer Screening After Positive Genetic Testing: Are Actionable Mutations Becoming "Unactionable"?
Comment on
-
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.J Clin Oncol. 2020 May 1;38(13):1398-1408. doi: 10.1200/JCO.19.02010. Epub 2020 Jan 10. J Clin Oncol. 2020. PMID: 31922925 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
